Epidural Morphine

Phase 3Small molecule

UUniversity of Colorado, Denver

Epidural Morphine is one of 19 small molecule programs targeting Analgesia. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

AnalgesiaRecruiting

AnalgesiaPhase 3

Recruiting

Competition

Competitive Landscape

20 competitors in Analgesia

#DrugCompanyPhaseTrials

Sufenta

LLeaf Vertical Inc.

Approved

3 2

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Approved

2 3

Penthrane

PPurdue Pharma, Canada

Phase 3

3 4

Ketalar

Boehringer Ingelheim

Phase 3

2 5

Oxycontin

PPurdue Pharma LP

Phase 3

1 6

Intrathecal Morphine

Pacira Pharmaceuticals, Inc

Phase 3

3 7

Esketamine Combined With Dexmedetomidine

TThe First Affiliated Hospital with Nanjing Medical University

Phase 3

1 8

Marcaine

IInnocoll

Phase 1

6 9

Kenalog

BBassett Healthcare

Phase 1

1 10

Narcan

SScienture

Phase 1

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Analgesia2 trials

Two Dose Epidural Morphine for Post-cesarean Analgesia

Terminated·—·Phase 4·NCT01844206·5 enrolled

Intrathecal Versus Epidural Morphine for Post-Cesarean Analgesia

Recruiting·HHospital Central do Funchal·Phase 4·NCT07386353·120 enrolled

Epidural1 trial

Low Dose Extended-release Epidural and Lumbar Plexus Block Compared to Lumbar Plexus Block for Total Hip Resurfacing

Terminated·WWake Forest University·Phase 4·NCT00934661·40 enrolled

Spinal Fusion1 trial

Intrathecal Morphine Versus Epidural Extended Release Morphine for Pediatric Patients Undergoing Spinal Fusion

Completed·UUniversity of Colorado, Denver·Phase 4·NCT00880607·84 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for Epidural Morphine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Epidural Morphine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Epidural Morphine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Colorado, Denver company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: UUniversity of Colorado, Denver

Epidural Morphine

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Analgesia2 trials

Epidural1 trial

Spinal Fusion1 trial

References

Drug Info

Quick Facts

Related News